{"id":350953,"date":"2025-08-25T20:18:59","date_gmt":"2025-08-25T20:18:59","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-alnylam-pharmaceuticals\/"},"modified":"2025-08-25T20:18:59","modified_gmt":"2025-08-25T20:18:59","slug":"how-to-buy-alnylam-pharmaceuticals","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-alnylam-pharmaceuticals\/","title":{"rendered":"Alnylam Pharmaceuticals, Inc. (ALNY) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Alnylam Pharmaceuticals, Inc. (ALNY) Hisse Senedi Yat\u0131r\u0131m\u0131"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334054,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-350953","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"Alnylam Pharmaceuticals, Inc. (ALNY) Hisseleri Nas\u0131l Al\u0131n\u0131r - Alnylam Pharmaceuticals, Inc. (ALNY) Hisse Senedi Yat\u0131r\u0131m\u0131","h1_source":{"label":"H1","type":"text","formatted_value":"Alnylam Pharmaceuticals, Inc. (ALNY) Hisseleri Nas\u0131l Al\u0131n\u0131r - Alnylam Pharmaceuticals, Inc. (ALNY) Hisse Senedi Yat\u0131r\u0131m\u0131"},"description":"Alnylam Pharmaceuticals, Inc. (ALNY) hisselerinin nas\u0131l al\u0131naca\u011f\u0131n\u0131 ve bu yenilik\u00e7i biyoteknoloji \u015firketine nas\u0131l yat\u0131r\u0131m yap\u0131laca\u011f\u0131n\u0131 \u00f6\u011frenin. G\u00fcncel hisse performans\u0131, riskler ve 2025 i\u00e7in b\u00fcy\u00fcme f\u0131rsatlar\u0131n\u0131 ke\u015ffedin.","description_source":{"label":"Description","type":"textarea","formatted_value":"Alnylam Pharmaceuticals, Inc. (ALNY) hisselerinin nas\u0131l al\u0131naca\u011f\u0131n\u0131 ve bu yenilik\u00e7i biyoteknoloji \u015firketine nas\u0131l yat\u0131r\u0131m yap\u0131laca\u011f\u0131n\u0131 \u00f6\u011frenin. G\u00fcncel hisse performans\u0131, riskler ve 2025 i\u00e7in b\u00fcy\u00fcme f\u0131rsatlar\u0131n\u0131 ke\u015ffedin."},"intro":"Genetik t\u0131pta devrim yaratan \u015firkete yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Alnylam Pharmaceuticals (ALNY), be\u015f onayl\u0131 ila\u00e7 ve patlay\u0131c\u0131 gelir b\u00fcy\u00fcmesi ile RNAi terap\u00f6tik devriminde \u00f6nc\u00fc konumda. Bu biyoteknoloji \u00f6nc\u00fcs\u00fc, hem son teknoloji bilimi hem de etkileyici finansal performans\u0131 sunuyor\u2014yenilik ve getiri arayan yat\u0131r\u0131mc\u0131lar i\u00e7in m\u00fckemmel.","intro_source":{"label":"Intro","type":"text","formatted_value":"Genetik t\u0131pta devrim yaratan \u015firkete yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Alnylam Pharmaceuticals (ALNY), be\u015f onayl\u0131 ila\u00e7 ve patlay\u0131c\u0131 gelir b\u00fcy\u00fcmesi ile RNAi terap\u00f6tik devriminde \u00f6nc\u00fc konumda. Bu biyoteknoloji \u00f6nc\u00fcs\u00fc, hem son teknoloji bilimi hem de etkileyici finansal performans\u0131 sunuyor\u2014yenilik ve getiri arayan yat\u0131r\u0131mc\u0131lar i\u00e7in m\u00fckemmel."},"body_html":"<h2>\ud83d\udcc8 Alnylam Hissesi: G\u00fcncel Fiyat ve Piyasa Konumu<\/h2> <p>25 A\u011fustos 2025 itibar\u0131yla, Alnylam Pharmaceuticals (ALNY) NASDAQ'ta <strong>454,38 $<\/strong> seviyesinde i\u015flem g\u00f6r\u00fcyor. Hisse senedi yak\u0131n zamanda 21 A\u011fustos 2025'te 467,55 $ ile t\u00fcm zamanlar\u0131n en y\u00fcksek seviyesine ula\u015ft\u0131 ve inan\u0131lmaz bir momentum sergiledi.<\/p> <p><strong>Takviminize not edin: 30 Ekim 2025 kritik bir tarih.<\/strong> Alnylam bu tarihte 3. \u00e7eyrek kazan\u00e7lar\u0131n\u0131 a\u00e7\u0131klayacak. Tarihsel olarak, bu raporlar fiyatlar\u0131 dramatik \u015fekilde hareket ettirir.<\/p> <h3>Kazan\u00e7 Raporlar\u0131n\u0131n ALNY Hissesini Hareket Ettirme \u015eekli:<\/h3> <table> <thead> <tr><th>Tarih<\/th><th>Olay<\/th><th>Haber \u00d6ncesi Fiyat<\/th><th>Haber Sonras\u0131 De\u011fi\u015fim<\/th><\/tr> <\/thead> <tbody> <tr><td>31 Tem 2025<\/td><td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>392,24 $<\/td><td>%15,9 Art\u0131\u015f (beklentileri %300 a\u015ft\u0131)<\/td><\/tr> <tr><td>30 Nis 2025<\/td><td>1. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>326,09 $<\/td><td>%20,3 Art\u0131\u015f (g\u00fc\u00e7l\u00fc gelir b\u00fcy\u00fcmesi)<\/td><\/tr> <tr><td>28 \u015eub 2025<\/td><td>Y\u0131ll\u0131k Sonu\u00e7lar<\/td><td>304,56 $<\/td><td>%6,8 Art\u0131\u015f (yol g\u00f6sterici art\u0131\u015f\u0131)<\/td><\/tr> <tr><td>31 Eki 2024<\/td><td>3. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>280,15 $<\/td><td>%8,7 Art\u0131\u015f (pipeline ilerlemesi)<\/td><\/tr> <tr><td>31 Tem 2024<\/td><td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>258,90 $<\/td><td>%8,2 Art\u0131\u015f (d\u00fczenleyici onaylar)<\/td><\/tr> <tr><td>30 Nis 2024<\/td><td>1. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>239,40 $<\/td><td>%8,1 Art\u0131\u015f (ticari geni\u015fleme)<\/td><\/tr> <\/tbody> <\/table> <p><strong>Trend \u0130\u00e7g\u00f6r\u00fcs\u00fc:<\/strong> Pozitif kazan\u00e7 s\u00fcrprizleri b\u00fcy\u00fck fiyat s\u0131\u00e7ramalar\u0131 yarat\u0131r. 2025 2. \u00e7eyrek s\u00fcrprizi sadece haftalar i\u00e7inde %15,9 art\u0131\u015f sa\u011flad\u0131. Negatif sonu\u00e7lar ge\u00e7ici d\u00fc\u015f\u00fc\u015flere neden olur, ancak ALNY g\u00fc\u00e7l\u00fc temelleri sayesinde s\u00fcrekli toparlan\u0131r.<\/p> <h3>6 Ayl\u0131k Fiyat Yolculu\u011fu (\u015eubat-A\u011fustos 2025)<\/h3> <p>Alnylam hisseleri bu d\u00f6nemde \u015fa\u015f\u0131rt\u0131c\u0131 bir <strong>%199 getiri<\/strong> sa\u011flad\u0131:<\/p> <ul> <li><strong>\u015eubat<\/strong>: ~151 $ (tatil sonras\u0131 konsolidasyon)<\/li> <li><strong>May\u0131s<\/strong>: 304,56 $ (1. \u00e7eyrek kazan\u00e7 s\u00fcrprizi ve yol g\u00f6sterici art\u0131\u015f\u0131)<\/li> <li><strong>Haziran<\/strong>: 326,09 $ (d\u00fczenleyici onay momentum)<\/li> <li><strong>Temmuz<\/strong>: 392,24 $ (2. \u00e7eyrek rekor kazan\u00e7lar +%64 gelir b\u00fcy\u00fcmesi)<\/li> <li><strong>A\u011fustos<\/strong>: 454,38 $ (geni\u015fleyen onaylarla t\u00fcm zamanlar\u0131n en y\u00fcksek seviyesi)<\/li> <\/ul> <h3>Patlay\u0131c\u0131 b\u00fcy\u00fcmenin nedeni nedir?<\/h3> <ul> <li>AMVUTTRA geliri ATTR-CM onay\u0131 ile patlad\u0131<\/li> <li>AB, \u0130ngiltere, Japonya, Brezilya'ya uluslararas\u0131 geni\u015fleme<\/li> <li>Yakla\u015f\u0131k 1.400 hasta AMVUTTRA tedavisi alt\u0131nda<\/li> <li>2025 gelir tahmini 2,65-2,8 milyar $ olarak y\u00fckseltildi<\/li> <\/ul> [cta_green text=\"Ticarete Ba\u015fla\"]<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030<\/h2> <ul> <li><strong>2025 (Y\u0131l Sonu):<\/strong> 480-520 $ (ticari uygulaman\u0131n devam\u0131 + 4. \u00e7eyrek kazan\u00e7lar\u0131) \u2192 <strong>G\u00dc\u00c7L\u00dc AL<\/strong><\/li> <li><strong>2026:<\/strong> 540-580 $ (hipertansiyon ilac\u0131 zilebesiran Faz III verileri)<\/li> <li><strong>2028:<\/strong> 650-720 $ (pipeline olgunla\u015fmas\u0131 + yeni endikasyonlar)<\/li> <li><strong>2030:<\/strong> 800+ $ (RNAi platformunun bir\u00e7ok hastal\u0131kta hakimiyeti)<\/li> <\/ul> <p><strong>Sonu\u00e7:<\/strong> Uzun vadeli b\u00fcy\u00fcme yat\u0131r\u0131mc\u0131lar\u0131 i\u00e7in ola\u011fan\u00fcst\u00fc. K\u0131sa vadede? Kazan\u00e7 sonras\u0131 f\u0131rsatlar\u0131 izleyin.<\/p> <h2>\u26a0\ufe0f Temel Riskler ve Pozitif Sinyaller<\/h2> <h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler:<\/h3> <ul> <li><strong>D\u00fczenleyici engeller:<\/strong> Yeni terapiler i\u00e7in FDA kararlar\u0131 gecikme veya reddedilme riski ta\u015f\u0131yor (<a href=\"https:\/\/monexa.ai\/blog\/alnylam-alny-rnai-therapeutics-earnings-beat-and-r-ALNY-2025-02-25\">D\u00fczenleyici Risk Analizi<\/a>)<\/li> <li><strong>Klinik deneme ba\u015far\u0131s\u0131zl\u0131klar\u0131:<\/strong> Pipeline adaylar\u0131 etkinlik\/g\u00fcvenlik g\u00f6stermeyebilir<\/li> <li><strong>Rekabet:<\/strong> RNAi pazar\u0131 alternatif platformlarla giderek daha rekabet\u00e7i hale geliyor<\/li> <li><strong>Fiyat bask\u0131lar\u0131:<\/strong> Enflasyon Azaltma Yasas\u0131 ve sa\u011fl\u0131k politikas\u0131 de\u011fi\u015fiklikleri<\/li> <li><strong>Geri \u00f6deme zorluklar\u0131:<\/strong> De\u011fer bazl\u0131 fiyatland\u0131rma \u00e7e\u015fitli sa\u011fl\u0131k sistemi engelleriyle kar\u015f\u0131la\u015f\u0131yor<\/li> <\/ul> <h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar:<\/h3> <ul> <li><strong>Gelir patlamas\u0131:<\/strong> 2025 2. \u00e7eyrek: 672M $ (+%64 Y\u0131ll\u0131k) ve 2,65-2,8 milyar $ yol g\u00f6sterici art\u0131\u015f\u0131<\/li> <li><strong>D\u00fczenleyici zaferler:<\/strong> AMVUTTRA AB, \u0130ngiltere, Japonya, Brezilya'da ATTR-CM i\u00e7in onayland\u0131<\/li> <li><strong>Pipeline momentum:<\/strong> 2025'te \u00fc\u00e7 b\u00fcy\u00fck Faz III denemesi ba\u015flat\u0131l\u0131yor<\/li> <li><strong>Hasta art\u0131\u015f\u0131:<\/strong> ~1.400 hasta AMVUTTRA tedavisi alt\u0131nda ve tedavi taban\u0131 geni\u015fliyor<\/li> <li><strong>Nakit g\u00fcc\u00fc:<\/strong> 2,86 milyar $ rezerv finansal istikrar sa\u011fl\u0131yor<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2> <ol> <li><strong>K\u00fc\u00e7\u00fck ba\u015flay\u0131n:<\/strong> Rahat oldu\u011funuz bir pozisyon b\u00fcy\u00fckl\u00fc\u011f\u00fc ile ba\u015flay\u0131n\u2014100 $ bile ba\u015flang\u0131\u00e7 i\u00e7in yeterlidir<\/li> <li><strong>Dolar maliyeti ortalamas\u0131 yap\u0131n:<\/strong> M\u00fckemmel giri\u015f zaman\u0131n\u0131 beklemek yerine d\u00fczenli yat\u0131r\u0131m yap\u0131n<\/li> <li><strong>Kazan\u00e7 uyar\u0131lar\u0131 ayarlay\u0131n:<\/strong> Potansiyel al\u0131m f\u0131rsatlar\u0131 i\u00e7in ALNY'yi 30 Ekim civar\u0131nda izleyin<\/li> <li><strong>Ak\u0131ll\u0131ca \u00e7e\u015fitlendirin:<\/strong> Biyoteknoloji maruziyetinizi toplam portf\u00f6y\u00fcn\u00fcz\u00fcn %10-15'i ile s\u0131n\u0131rlay\u0131n<\/li> <li><strong>Esprili yakla\u015f\u0131m:<\/strong> \"ALNY ticareti, bilimsel ke\u015ffin a\u00e7\u0131\u011fa \u00e7\u0131k\u0131\u015f\u0131n\u0131 izlemek gibidir\u2014bazen sonu\u00e7lar\u0131 g\u00f6rmek i\u00e7in deneyin \u00e7al\u0131\u015fmas\u0131na izin vermeniz gerekir!\"<\/li> <\/ol> <h2>\u2705 Alnylam Pharmaceuticals, Inc. (ALNY) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ad\u0131m Ad\u0131m<\/h2> <table> <thead> <tr><th>Ad\u0131m<\/th><th>\u0130\u015flem<\/th><th>Neden \u00d6nemli<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Bir ticaret platformu se\u00e7in<\/td><td>NASDAQ listeleri ve kesirli hisse sunan bir platform oldu\u011fundan emin olun<\/td><\/tr> <tr><td>2<\/td><td>Hesap do\u011frulamas\u0131n\u0131 tamamlay\u0131n<\/td><td>Kimlik ve fon bilgisi sa\u011flay\u0131n (genellikle 1-2 g\u00fcn s\u00fcrer)<\/td><\/tr> <tr><td>3<\/td><td>Fon yat\u0131r\u0131n<\/td><td>Risk almaya haz\u0131r oldu\u011funuz bir miktarla ba\u015flay\u0131n<\/td><\/tr> <tr><td>4<\/td><td>\"ALNY\" aramas\u0131 yap\u0131n<\/td><td>Sadece \u015firket ad\u0131 de\u011fil, sembol\u00fc kullan\u0131n<\/td><\/tr> <tr><td>5<\/td><td>Sipari\u015f t\u00fcr\u00fcn\u00fc se\u00e7in<\/td><td>Giri\u015f fiyat\u0131n\u0131 kontrol etmek i\u00e7in limit emirleri kullan\u0131n; piyasa emirlerinden ka\u00e7\u0131n\u0131n<\/td><\/tr> <tr><td>6<\/td><td>\u0130nceleyin ve onaylay\u0131n<\/td><td>Komisyon \u00fccretleri ve toplam maliyeti kontrol edin<\/td><\/tr> <tr><td>7<\/td><td>Pozisyonunuzu izleyin<\/td><td>\u00d6nemli seviyeler ve haber olaylar\u0131 i\u00e7in fiyat uyar\u0131lar\u0131 ayarlay\u0131n<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Neden Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Uygun?<\/h2> <p>Pocket Option, hisse senedi yat\u0131r\u0131m\u0131n\u0131 herkes i\u00e7in eri\u015filebilir k\u0131lar:<\/p> <ul> <li><strong>Minimum depozito: 5 $<\/strong> \u2014 Stratejileri d\u00fc\u015f\u00fck riskle test etmek i\u00e7in m\u00fckemmel<\/li> <li><strong>1 dakikal\u0131k KYC do\u011frulamas\u0131<\/strong> \u2014 Herhangi bir resmi kimlik y\u00fckleyin ve hemen ticarete ba\u015flay\u0131n<\/li> <li><strong>100+ para \u00e7ekme y\u00f6ntemi<\/strong> \u2014 Kripto, e-c\u00fczdanlar, banka kartlar\u0131 ve yerel se\u00e7enekler<\/li> <li><strong>Kesirli hisse imkan\u0131<\/strong> \u2014 ALNY gibi pahal\u0131 hisselere k\u00fc\u00e7\u00fck miktarlarla yat\u0131r\u0131m yap\u0131n<\/li> <li><strong>Kullan\u0131c\u0131 dostu platform<\/strong> \u2014 Yeni ba\u015flayanlar i\u00e7in tasarlanm\u0131\u015f sezgisel aray\u00fcz<\/li> <\/ul> <h2>\ud83c\udf0d 2025'te Alnylam: RNAi Devrimi Lideri<\/h2> <p>Alnylam Pharmaceuticals, be\u015f onayl\u0131 ila\u00e7 ve 20'den fazla klinik program i\u00e7eren pipeline ile RNAi terap\u00f6tik pazar\u0131nda hakimdir. \u015eirket, 2002'den beri \"RNAi Devrimi\"ni ba\u015flatarak Nobel \u00d6d\u00fcll\u00fc bilimi hayat de\u011fi\u015ftiren tedavilere d\u00f6n\u00fc\u015ft\u00fcrm\u00fc\u015ft\u00fcr.<\/p> <h3>G\u00fcncel Piyasa Konumu:<\/h3> <ul> <li><strong>Gelir devi:<\/strong> 2025 2. \u00e7eyrek 672M $ (+%64 b\u00fcy\u00fcme)<\/li> <li><strong>Nakit zengini:<\/strong> 2,86 milyar $ rezerv<\/li> <li><strong>K\u00fcresel eri\u015fim:<\/strong> ABD, AB, \u0130ngiltere, Japonya, Brezilya'da ila\u00e7lar mevcut<\/li> <li><strong>Pipeline derinli\u011fi:<\/strong> 2025 sonunda 25'ten fazla klinik program<\/li> <\/ul> <h3>Terap\u00f6tik Odak:<\/h3> <ul> <li>TTR amiloidozu (AMVUTTRA, ONPATTRO)<\/li> <li>Nadir metabolik bozukluklar (GIVLAARI, OXLUMO)<\/li> <li>Kardiyovask\u00fcler hastal\u0131k (geli\u015fim a\u015famas\u0131nda zilebesiran)<\/li> <li>N\u00f6roloji ve di\u011fer yayg\u0131n durumlar<\/li> <\/ul> <p><strong>2025 \u0130lgin\u00e7 Ger\u00e7ek:<\/strong> Alnylam bilim insanlar\u0131, y\u0131lda sadece bir veya iki doz uygulanabilen RNAi terap\u00f6tikleri geli\u015ftirdi\u2014kronik hastal\u0131k tedavisinde ve hasta konforunda devrim yarat\u0131yor!<\/p> <p>Daha fazla i\u00e7g\u00f6r\u00fc ve ticaret stratejileri i\u00e7in, karma\u015f\u0131k piyasa kavramlar\u0131n\u0131 g\u00fcnl\u00fck yat\u0131r\u0131mc\u0131lar i\u00e7in uygulanabilir tavsiyelere d\u00f6n\u00fc\u015ft\u00fcrd\u00fc\u011f\u00fcm\u00fcz <a href=\"\/blog\">Pocket Option blog<\/a>'unu ziyaret edin.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 Alnylam Hissesi: G\u00fcncel Fiyat ve Piyasa Konumu<\/h2>\n<p>25 A\u011fustos 2025 itibar\u0131yla, Alnylam Pharmaceuticals (ALNY) NASDAQ&#8217;ta <strong>454,38 $<\/strong> seviyesinde i\u015flem g\u00f6r\u00fcyor. Hisse senedi yak\u0131n zamanda 21 A\u011fustos 2025&#8217;te 467,55 $ ile t\u00fcm zamanlar\u0131n en y\u00fcksek seviyesine ula\u015ft\u0131 ve inan\u0131lmaz bir momentum sergiledi.<\/p>\n<p><strong>Takviminize not edin: 30 Ekim 2025 kritik bir tarih.<\/strong> Alnylam bu tarihte 3. \u00e7eyrek kazan\u00e7lar\u0131n\u0131 a\u00e7\u0131klayacak. Tarihsel olarak, bu raporlar fiyatlar\u0131 dramatik \u015fekilde hareket ettirir.<\/p>\n<h3>Kazan\u00e7 Raporlar\u0131n\u0131n ALNY Hissesini Hareket Ettirme \u015eekli:<\/h3>\n<table>\n<thead>\n<tr>\n<th>Tarih<\/th>\n<th>Olay<\/th>\n<th>Haber \u00d6ncesi Fiyat<\/th>\n<th>Haber Sonras\u0131 De\u011fi\u015fim<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>31 Tem 2025<\/td>\n<td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>392,24 $<\/td>\n<td>%15,9 Art\u0131\u015f (beklentileri %300 a\u015ft\u0131)<\/td>\n<\/tr>\n<tr>\n<td>30 Nis 2025<\/td>\n<td>1. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>326,09 $<\/td>\n<td>%20,3 Art\u0131\u015f (g\u00fc\u00e7l\u00fc gelir b\u00fcy\u00fcmesi)<\/td>\n<\/tr>\n<tr>\n<td>28 \u015eub 2025<\/td>\n<td>Y\u0131ll\u0131k Sonu\u00e7lar<\/td>\n<td>304,56 $<\/td>\n<td>%6,8 Art\u0131\u015f (yol g\u00f6sterici art\u0131\u015f\u0131)<\/td>\n<\/tr>\n<tr>\n<td>31 Eki 2024<\/td>\n<td>3. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>280,15 $<\/td>\n<td>%8,7 Art\u0131\u015f (pipeline ilerlemesi)<\/td>\n<\/tr>\n<tr>\n<td>31 Tem 2024<\/td>\n<td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>258,90 $<\/td>\n<td>%8,2 Art\u0131\u015f (d\u00fczenleyici onaylar)<\/td>\n<\/tr>\n<tr>\n<td>30 Nis 2024<\/td>\n<td>1. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>239,40 $<\/td>\n<td>%8,1 Art\u0131\u015f (ticari geni\u015fleme)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Trend \u0130\u00e7g\u00f6r\u00fcs\u00fc:<\/strong> Pozitif kazan\u00e7 s\u00fcrprizleri b\u00fcy\u00fck fiyat s\u0131\u00e7ramalar\u0131 yarat\u0131r. 2025 2. \u00e7eyrek s\u00fcrprizi sadece haftalar i\u00e7inde %15,9 art\u0131\u015f sa\u011flad\u0131. Negatif sonu\u00e7lar ge\u00e7ici d\u00fc\u015f\u00fc\u015flere neden olur, ancak ALNY g\u00fc\u00e7l\u00fc temelleri sayesinde s\u00fcrekli toparlan\u0131r.<\/p>\n<h3>6 Ayl\u0131k Fiyat Yolculu\u011fu (\u015eubat-A\u011fustos 2025)<\/h3>\n<p>Alnylam hisseleri bu d\u00f6nemde \u015fa\u015f\u0131rt\u0131c\u0131 bir <strong>%199 getiri<\/strong> sa\u011flad\u0131:<\/p>\n<ul>\n<li><strong>\u015eubat<\/strong>: ~151 $ (tatil sonras\u0131 konsolidasyon)<\/li>\n<li><strong>May\u0131s<\/strong>: 304,56 $ (1. \u00e7eyrek kazan\u00e7 s\u00fcrprizi ve yol g\u00f6sterici art\u0131\u015f\u0131)<\/li>\n<li><strong>Haziran<\/strong>: 326,09 $ (d\u00fczenleyici onay momentum)<\/li>\n<li><strong>Temmuz<\/strong>: 392,24 $ (2. \u00e7eyrek rekor kazan\u00e7lar +%64 gelir b\u00fcy\u00fcmesi)<\/li>\n<li><strong>A\u011fustos<\/strong>: 454,38 $ (geni\u015fleyen onaylarla t\u00fcm zamanlar\u0131n en y\u00fcksek seviyesi)<\/li>\n<\/ul>\n<h3>Patlay\u0131c\u0131 b\u00fcy\u00fcmenin nedeni nedir?<\/h3>\n<ul>\n<li>AMVUTTRA geliri ATTR-CM onay\u0131 ile patlad\u0131<\/li>\n<li>AB, \u0130ngiltere, Japonya, Brezilya&#8217;ya uluslararas\u0131 geni\u015fleme<\/li>\n<li>Yakla\u015f\u0131k 1.400 hasta AMVUTTRA tedavisi alt\u0131nda<\/li>\n<li>2025 gelir tahmini 2,65-2,8 milyar $ olarak y\u00fckseltildi<\/li>\n<\/ul>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/tr\/register\/\" class=\"po-cta-green\">Ticarete Ba\u015fla\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030<\/h2>\n<ul>\n<li><strong>2025 (Y\u0131l Sonu):<\/strong> 480-520 $ (ticari uygulaman\u0131n devam\u0131 + 4. \u00e7eyrek kazan\u00e7lar\u0131) \u2192 <strong>G\u00dc\u00c7L\u00dc AL<\/strong><\/li>\n<li><strong>2026:<\/strong> 540-580 $ (hipertansiyon ilac\u0131 zilebesiran Faz III verileri)<\/li>\n<li><strong>2028:<\/strong> 650-720 $ (pipeline olgunla\u015fmas\u0131 + yeni endikasyonlar)<\/li>\n<li><strong>2030:<\/strong> 800+ $ (RNAi platformunun bir\u00e7ok hastal\u0131kta hakimiyeti)<\/li>\n<\/ul>\n<p><strong>Sonu\u00e7:<\/strong> Uzun vadeli b\u00fcy\u00fcme yat\u0131r\u0131mc\u0131lar\u0131 i\u00e7in ola\u011fan\u00fcst\u00fc. K\u0131sa vadede? Kazan\u00e7 sonras\u0131 f\u0131rsatlar\u0131 izleyin.<\/p>\n<h2>\u26a0\ufe0f Temel Riskler ve Pozitif Sinyaller<\/h2>\n<h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler:<\/h3>\n<ul>\n<li><strong>D\u00fczenleyici engeller:<\/strong> Yeni terapiler i\u00e7in FDA kararlar\u0131 gecikme veya reddedilme riski ta\u015f\u0131yor (<a href=\"https:\/\/monexa.ai\/blog\/alnylam-alny-rnai-therapeutics-earnings-beat-and-r-ALNY-2025-02-25\">D\u00fczenleyici Risk Analizi<\/a>)<\/li>\n<li><strong>Klinik deneme ba\u015far\u0131s\u0131zl\u0131klar\u0131:<\/strong> Pipeline adaylar\u0131 etkinlik\/g\u00fcvenlik g\u00f6stermeyebilir<\/li>\n<li><strong>Rekabet:<\/strong> RNAi pazar\u0131 alternatif platformlarla giderek daha rekabet\u00e7i hale geliyor<\/li>\n<li><strong>Fiyat bask\u0131lar\u0131:<\/strong> Enflasyon Azaltma Yasas\u0131 ve sa\u011fl\u0131k politikas\u0131 de\u011fi\u015fiklikleri<\/li>\n<li><strong>Geri \u00f6deme zorluklar\u0131:<\/strong> De\u011fer bazl\u0131 fiyatland\u0131rma \u00e7e\u015fitli sa\u011fl\u0131k sistemi engelleriyle kar\u015f\u0131la\u015f\u0131yor<\/li>\n<\/ul>\n<h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar:<\/h3>\n<ul>\n<li><strong>Gelir patlamas\u0131:<\/strong> 2025 2. \u00e7eyrek: 672M $ (+%64 Y\u0131ll\u0131k) ve 2,65-2,8 milyar $ yol g\u00f6sterici art\u0131\u015f\u0131<\/li>\n<li><strong>D\u00fczenleyici zaferler:<\/strong> AMVUTTRA AB, \u0130ngiltere, Japonya, Brezilya&#8217;da ATTR-CM i\u00e7in onayland\u0131<\/li>\n<li><strong>Pipeline momentum:<\/strong> 2025&#8217;te \u00fc\u00e7 b\u00fcy\u00fck Faz III denemesi ba\u015flat\u0131l\u0131yor<\/li>\n<li><strong>Hasta art\u0131\u015f\u0131:<\/strong> ~1.400 hasta AMVUTTRA tedavisi alt\u0131nda ve tedavi taban\u0131 geni\u015fliyor<\/li>\n<li><strong>Nakit g\u00fcc\u00fc:<\/strong> 2,86 milyar $ rezerv finansal istikrar sa\u011fl\u0131yor<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2>\n<ol>\n<li><strong>K\u00fc\u00e7\u00fck ba\u015flay\u0131n:<\/strong> Rahat oldu\u011funuz bir pozisyon b\u00fcy\u00fckl\u00fc\u011f\u00fc ile ba\u015flay\u0131n\u2014100 $ bile ba\u015flang\u0131\u00e7 i\u00e7in yeterlidir<\/li>\n<li><strong>Dolar maliyeti ortalamas\u0131 yap\u0131n:<\/strong> M\u00fckemmel giri\u015f zaman\u0131n\u0131 beklemek yerine d\u00fczenli yat\u0131r\u0131m yap\u0131n<\/li>\n<li><strong>Kazan\u00e7 uyar\u0131lar\u0131 ayarlay\u0131n:<\/strong> Potansiyel al\u0131m f\u0131rsatlar\u0131 i\u00e7in ALNY&#8217;yi 30 Ekim civar\u0131nda izleyin<\/li>\n<li><strong>Ak\u0131ll\u0131ca \u00e7e\u015fitlendirin:<\/strong> Biyoteknoloji maruziyetinizi toplam portf\u00f6y\u00fcn\u00fcz\u00fcn %10-15&#8217;i ile s\u0131n\u0131rlay\u0131n<\/li>\n<li><strong>Esprili yakla\u015f\u0131m:<\/strong> &#8220;ALNY ticareti, bilimsel ke\u015ffin a\u00e7\u0131\u011fa \u00e7\u0131k\u0131\u015f\u0131n\u0131 izlemek gibidir\u2014bazen sonu\u00e7lar\u0131 g\u00f6rmek i\u00e7in deneyin \u00e7al\u0131\u015fmas\u0131na izin vermeniz gerekir!&#8221;<\/li>\n<\/ol>\n<h2>\u2705 Alnylam Pharmaceuticals, Inc. (ALNY) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Ad\u0131m Ad\u0131m<\/h2>\n<table>\n<thead>\n<tr>\n<th>Ad\u0131m<\/th>\n<th>\u0130\u015flem<\/th>\n<th>Neden \u00d6nemli<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Bir ticaret platformu se\u00e7in<\/td>\n<td>NASDAQ listeleri ve kesirli hisse sunan bir platform oldu\u011fundan emin olun<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Hesap do\u011frulamas\u0131n\u0131 tamamlay\u0131n<\/td>\n<td>Kimlik ve fon bilgisi sa\u011flay\u0131n (genellikle 1-2 g\u00fcn s\u00fcrer)<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>Fon yat\u0131r\u0131n<\/td>\n<td>Risk almaya haz\u0131r oldu\u011funuz bir miktarla ba\u015flay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>&#8220;ALNY&#8221; aramas\u0131 yap\u0131n<\/td>\n<td>Sadece \u015firket ad\u0131 de\u011fil, sembol\u00fc kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Sipari\u015f t\u00fcr\u00fcn\u00fc se\u00e7in<\/td>\n<td>Giri\u015f fiyat\u0131n\u0131 kontrol etmek i\u00e7in limit emirleri kullan\u0131n; piyasa emirlerinden ka\u00e7\u0131n\u0131n<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>\u0130nceleyin ve onaylay\u0131n<\/td>\n<td>Komisyon \u00fccretleri ve toplam maliyeti kontrol edin<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Pozisyonunuzu izleyin<\/td>\n<td>\u00d6nemli seviyeler ve haber olaylar\u0131 i\u00e7in fiyat uyar\u0131lar\u0131 ayarlay\u0131n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Neden Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Uygun?<\/h2>\n<p>Pocket Option, hisse senedi yat\u0131r\u0131m\u0131n\u0131 herkes i\u00e7in eri\u015filebilir k\u0131lar:<\/p>\n<ul>\n<li><strong>Minimum depozito: 5 $<\/strong> \u2014 Stratejileri d\u00fc\u015f\u00fck riskle test etmek i\u00e7in m\u00fckemmel<\/li>\n<li><strong>1 dakikal\u0131k KYC do\u011frulamas\u0131<\/strong> \u2014 Herhangi bir resmi kimlik y\u00fckleyin ve hemen ticarete ba\u015flay\u0131n<\/li>\n<li><strong>100+ para \u00e7ekme y\u00f6ntemi<\/strong> \u2014 Kripto, e-c\u00fczdanlar, banka kartlar\u0131 ve yerel se\u00e7enekler<\/li>\n<li><strong>Kesirli hisse imkan\u0131<\/strong> \u2014 ALNY gibi pahal\u0131 hisselere k\u00fc\u00e7\u00fck miktarlarla yat\u0131r\u0131m yap\u0131n<\/li>\n<li><strong>Kullan\u0131c\u0131 dostu platform<\/strong> \u2014 Yeni ba\u015flayanlar i\u00e7in tasarlanm\u0131\u015f sezgisel aray\u00fcz<\/li>\n<\/ul>\n<h2>\ud83c\udf0d 2025&#8217;te Alnylam: RNAi Devrimi Lideri<\/h2>\n<p>Alnylam Pharmaceuticals, be\u015f onayl\u0131 ila\u00e7 ve 20&#8217;den fazla klinik program i\u00e7eren pipeline ile RNAi terap\u00f6tik pazar\u0131nda hakimdir. \u015eirket, 2002&#8217;den beri &#8220;RNAi Devrimi&#8221;ni ba\u015flatarak Nobel \u00d6d\u00fcll\u00fc bilimi hayat de\u011fi\u015ftiren tedavilere d\u00f6n\u00fc\u015ft\u00fcrm\u00fc\u015ft\u00fcr.<\/p>\n<h3>G\u00fcncel Piyasa Konumu:<\/h3>\n<ul>\n<li><strong>Gelir devi:<\/strong> 2025 2. \u00e7eyrek 672M $ (+%64 b\u00fcy\u00fcme)<\/li>\n<li><strong>Nakit zengini:<\/strong> 2,86 milyar $ rezerv<\/li>\n<li><strong>K\u00fcresel eri\u015fim:<\/strong> ABD, AB, \u0130ngiltere, Japonya, Brezilya&#8217;da ila\u00e7lar mevcut<\/li>\n<li><strong>Pipeline derinli\u011fi:<\/strong> 2025 sonunda 25&#8217;ten fazla klinik program<\/li>\n<\/ul>\n<h3>Terap\u00f6tik Odak:<\/h3>\n<ul>\n<li>TTR amiloidozu (AMVUTTRA, ONPATTRO)<\/li>\n<li>Nadir metabolik bozukluklar (GIVLAARI, OXLUMO)<\/li>\n<li>Kardiyovask\u00fcler hastal\u0131k (geli\u015fim a\u015famas\u0131nda zilebesiran)<\/li>\n<li>N\u00f6roloji ve di\u011fer yayg\u0131n durumlar<\/li>\n<\/ul>\n<p><strong>2025 \u0130lgin\u00e7 Ger\u00e7ek:<\/strong> Alnylam bilim insanlar\u0131, y\u0131lda sadece bir veya iki doz uygulanabilen RNAi terap\u00f6tikleri geli\u015ftirdi\u2014kronik hastal\u0131k tedavisinde ve hasta konforunda devrim yarat\u0131yor!<\/p>\n<p>Daha fazla i\u00e7g\u00f6r\u00fc ve ticaret stratejileri i\u00e7in, karma\u015f\u0131k piyasa kavramlar\u0131n\u0131 g\u00fcnl\u00fck yat\u0131r\u0131mc\u0131lar i\u00e7in uygulanabilir tavsiyelere d\u00f6n\u00fc\u015ft\u00fcrd\u00fc\u011f\u00fcm\u00fcz <a href=\"\/blog\">Pocket Option blog<\/a>&#8216;unu ziyaret edin.<\/p>\n"},"faq":[{"question":"Alnylam Pharmaceuticals hisseleri nas\u0131l sat\u0131n al\u0131n\u0131r?","answer":"Bir ticaret platformu se\u00e7in, hesap do\u011frulamas\u0131n\u0131 tamamlay\u0131n, fon yat\u0131r\u0131n, ALNY sembol\u00fcn\u00fc aray\u0131n, limit emri verin ve pozisyonunuzu izleyin."},{"question":"Alnylam hisselerinin 2025 fiyat tahmini nedir?","answer":"2025 y\u0131l sonunda fiyat\u0131n 480-520 $ aras\u0131nda olmas\u0131 bekleniyor ve g\u00fc\u00e7l\u00fc al\u0131m \u00f6neriliyor."},{"question":"Alnylam'\u0131n en b\u00fcy\u00fck riskleri nelerdir?","answer":"D\u00fczenleyici engeller, klinik deneme ba\u015far\u0131s\u0131zl\u0131klar\u0131, artan rekabet, fiyat bask\u0131lar\u0131 ve geri \u00f6deme zorluklar\u0131 ba\u015fl\u0131ca risklerdir."},{"question":"Yeni ba\u015flayanlar Alnylam hissesi al\u0131rken nelere dikkat etmeli?","answer":"K\u00fc\u00e7\u00fck ba\u015flay\u0131n, d\u00fczenli yat\u0131r\u0131m yap\u0131n, kazan\u00e7 uyar\u0131lar\u0131 kurun, portf\u00f6y\u00fcn\u00fcz\u00fc \u00e7e\u015fitlendirin ve piyasa hareketlerini takip edin."},{"question":"Pocket Option neden yeni yat\u0131r\u0131mc\u0131lar i\u00e7in uygundur?","answer":"D\u00fc\u015f\u00fck minimum depozito, h\u0131zl\u0131 KYC do\u011frulamas\u0131, \u00e7ok say\u0131da para \u00e7ekme y\u00f6ntemi, kesirli hisse imkan\u0131 ve kullan\u0131c\u0131 dostu aray\u00fcz sunar."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Alnylam Pharmaceuticals hisseleri nas\u0131l sat\u0131n al\u0131n\u0131r?","answer":"Bir ticaret platformu se\u00e7in, hesap do\u011frulamas\u0131n\u0131 tamamlay\u0131n, fon yat\u0131r\u0131n, ALNY sembol\u00fcn\u00fc aray\u0131n, limit emri verin ve pozisyonunuzu izleyin."},{"question":"Alnylam hisselerinin 2025 fiyat tahmini nedir?","answer":"2025 y\u0131l sonunda fiyat\u0131n 480-520 $ aras\u0131nda olmas\u0131 bekleniyor ve g\u00fc\u00e7l\u00fc al\u0131m \u00f6neriliyor."},{"question":"Alnylam'\u0131n en b\u00fcy\u00fck riskleri nelerdir?","answer":"D\u00fczenleyici engeller, klinik deneme ba\u015far\u0131s\u0131zl\u0131klar\u0131, artan rekabet, fiyat bask\u0131lar\u0131 ve geri \u00f6deme zorluklar\u0131 ba\u015fl\u0131ca risklerdir."},{"question":"Yeni ba\u015flayanlar Alnylam hissesi al\u0131rken nelere dikkat etmeli?","answer":"K\u00fc\u00e7\u00fck ba\u015flay\u0131n, d\u00fczenli yat\u0131r\u0131m yap\u0131n, kazan\u00e7 uyar\u0131lar\u0131 kurun, portf\u00f6y\u00fcn\u00fcz\u00fc \u00e7e\u015fitlendirin ve piyasa hareketlerini takip edin."},{"question":"Pocket Option neden yeni yat\u0131r\u0131mc\u0131lar i\u00e7in uygundur?","answer":"D\u00fc\u015f\u00fck minimum depozito, h\u0131zl\u0131 KYC do\u011frulamas\u0131, \u00e7ok say\u0131da para \u00e7ekme y\u00f6ntemi, kesirli hisse imkan\u0131 ve kullan\u0131c\u0131 dostu aray\u00fcz sunar."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Alnylam Pharmaceuticals, Inc. (ALNY) Hisseleri Nas\u0131l Al\u0131n\u0131r - Alnylam Pharmaceuticals, Inc. (ALNY) Hisse Senedi Yat\u0131r\u0131m\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-alnylam-pharmaceuticals\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Alnylam Pharmaceuticals, Inc. (ALNY) Hisseleri Nas\u0131l Al\u0131n\u0131r - Alnylam Pharmaceuticals, Inc. (ALNY) Hisse Senedi Yat\u0131r\u0131m\u0131\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-alnylam-pharmaceuticals\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-25T20:18:59+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-alnylam-pharmaceuticals\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-alnylam-pharmaceuticals\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"Alnylam Pharmaceuticals, Inc. (ALNY) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Alnylam Pharmaceuticals, Inc. (ALNY) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"datePublished\":\"2025-08-25T20:18:59+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-alnylam-pharmaceuticals\/\"},\"wordCount\":21,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-alnylam-pharmaceuticals\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-alnylam-pharmaceuticals\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-alnylam-pharmaceuticals\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-alnylam-pharmaceuticals\/\",\"name\":\"Alnylam Pharmaceuticals, Inc. (ALNY) Hisseleri Nas\u0131l Al\u0131n\u0131r - Alnylam Pharmaceuticals, Inc. (ALNY) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-alnylam-pharmaceuticals\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-alnylam-pharmaceuticals\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp\",\"datePublished\":\"2025-08-25T20:18:59+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-alnylam-pharmaceuticals\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-alnylam-pharmaceuticals\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-alnylam-pharmaceuticals\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-alnylam-pharmaceuticals\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Alnylam Pharmaceuticals, Inc. (ALNY) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Alnylam Pharmaceuticals, Inc. (ALNY) Hisse Senedi Yat\u0131r\u0131m\u0131\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Alnylam Pharmaceuticals, Inc. (ALNY) Hisseleri Nas\u0131l Al\u0131n\u0131r - Alnylam Pharmaceuticals, Inc. (ALNY) Hisse Senedi Yat\u0131r\u0131m\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-alnylam-pharmaceuticals\/","og_locale":"tr_TR","og_type":"article","og_title":"Alnylam Pharmaceuticals, Inc. (ALNY) Hisseleri Nas\u0131l Al\u0131n\u0131r - Alnylam Pharmaceuticals, Inc. (ALNY) Hisse Senedi Yat\u0131r\u0131m\u0131","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-alnylam-pharmaceuticals\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-25T20:18:59+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-alnylam-pharmaceuticals\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-alnylam-pharmaceuticals\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"Alnylam Pharmaceuticals, Inc. (ALNY) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Alnylam Pharmaceuticals, Inc. (ALNY) Hisse Senedi Yat\u0131r\u0131m\u0131","datePublished":"2025-08-25T20:18:59+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-alnylam-pharmaceuticals\/"},"wordCount":21,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-alnylam-pharmaceuticals\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-alnylam-pharmaceuticals\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-alnylam-pharmaceuticals\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-alnylam-pharmaceuticals\/","name":"Alnylam Pharmaceuticals, Inc. (ALNY) Hisseleri Nas\u0131l Al\u0131n\u0131r - Alnylam Pharmaceuticals, Inc. (ALNY) Hisse Senedi Yat\u0131r\u0131m\u0131","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-alnylam-pharmaceuticals\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-alnylam-pharmaceuticals\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp","datePublished":"2025-08-25T20:18:59+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-alnylam-pharmaceuticals\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-alnylam-pharmaceuticals\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-alnylam-pharmaceuticals\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-alnylam-pharmaceuticals\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"Alnylam Pharmaceuticals, Inc. (ALNY) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Alnylam Pharmaceuticals, Inc. (ALNY) Hisse Senedi Yat\u0131r\u0131m\u0131"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":350955,"slug":"how-to-buy-alnylam-pharmaceuticals","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Alnylam Pharmaceuticals, Inc. (ALNY) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Alnylam Pharmaceuticals, Inc. (ALNY)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-alnylam-pharmaceuticals\/"},"pt_AA":{"locale":"pt_AA","id":350952,"slug":"how-to-buy-alnylam-pharmaceuticals","post_title":"Como comprar a\u00e7\u00f5es da Alnylam Pharmaceuticals, Inc. (ALNY) - Investimento em a\u00e7\u00f5es da Alnylam Pharmaceuticals, Inc. (ALNY)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-alnylam-pharmaceuticals\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/350953","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=350953"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/350953\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/334054"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=350953"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=350953"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=350953"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}